Blue Jet Healthcare Ltd IPO - Check Issue Date, Price, Lot Size & Details with BlinkX.

Blue Jet Healthcare Ltd IPO

Blue Jet Healthcare Limited develops and supplies speciality pharmaceutical and healthcare ingredients and intermediates under a contract development and manufacturing organization business model. The Company has specialized chemistry capabilities in contrast media intermediates and high-intensity sweeteners. The Company has built a long-term customer base of innovator and multi-national generic pharmaceutical companies, supported by multi-year contracts. It supplies a critical starting intermediate and several advanced intermediates to three of the largest contrast media manufacturers in the world, including GE Healthcare AS, Guerbet Group, and Bracco Imaging S.p.A. It also supplies high-intensity sweeteners to several multi-national companies, including Colgate Palmolive (India) Limited and Unilever.

Blue Jet Healthcare Ltd IPO Details

Total Shares Offered

₹ 2,42,85,160

Offer to Public

2,42,85,160

Retail Max (Shares)

₹ 84,99,806

Pre Issue Promoters Holding

₹ 17,34,65,385

Exchange

BSE

Issue size

₹ 840.27 Cr

IPO Open Date

Oct 25, 2023

Close Date

Oct 27, 2023

Lot Size

Min Investment

₹ 14,147

Issue Type

Book Building

Listing Date

Nov 1, 2023

Blue Jet Healthcare Ltd IPO Dates

Oct 25, 2023

Opening date

Oct 27, 2023

Closing date

Oct 30, 2023

Basis of Allotment

Oct 30, 2023

Initiation of Refunds

Oct 31, 2023

Credit of Shares

Nov 1, 2023

Listing date

Details

Sector	Type
Sector	Pharmaceuticals - Indian - Bulk Drugs & Formln
Sub Sector	NA
Issue Type	Book Building

Subscription Status

*Values are in Lakhs

Investor Type	Subscription Times	Shares Offered*
QIB	0x	12142580
NII	0x	3642774
Retail	0x	8499806
Employee	0x	0
Total	0x	24285160

Investor Type

QIB

NII

Retail

Employee

Total

Subscription Times

12142580

3642774

8499806

24285160

Blue Jet Healthcare Ltd Financial Status

Income Statement

Particulars (In Rs. Crores)

Balance Sheet

Particulars (In Rs. Crores)

Particulars (in Rs. Crores)	FY23	FY22	FY21
Revenue from operations	423.89	248.19	241.69
EBITDA	441.68	276.28	266.76
PAT	305.20	163.75	160.03
Total Assets	821.33	471.91	477.21
Share Capital	34.69	34.69	34.69
Total Borrowings	88.09	80.43	46.54
Operating Activities (Net Cash)	322.99	191.84	185.10
Investing Activities (Net Cash)	97.53	103.43	158.82
Financing Activities (Net Cash)	88.09	80.43	46.54
Net Cashflow	119.79	84.71	65.63

About Blue Jet Healthcare Ltd

Blue Jet Healthcare Limited was originally incorporated as `Jet Chemicals Private Limited,' under the provisions of the Companies Act, 1956, at Mumbai, pursuant to a certificate of incorporation dated December 7, 1968, issued by the Registrar of Companies, Maharashtra at Mumbai. Pursuant to its Shareholders' resolution dated December 28, 2020, the name of the Company was changed to 'Blue Jet Healthcare Private Limited', and a fresh certificate of incorporation dated December 30, 2020, was issued by the Registrar of Companies, Maharashtra at Mumbai. Subsequently, the Company was converted into a public limited company, and pursuant to a special resolution of its Shareholders dated May 5, 2022, and the name of the Company was changed to `Blue Jet Healthcare Limited' A fresh certificate of incorporation was issued by Registrar of Companies, Maharashtra, at Mumbai on May 18, 2022.

The moving annual turnover1 of the global contrast media formulation market was approximately US$5.9 billion for June 2023, and is forecasted to grow at a CAGR of 6% to 8% between calendar years 2023 and 2025, primarily led by increased volumes. The global high-intensity sweetener market was approximately US$2.9 billion to US$3.0 billion, as of the calendar year 2023. The end product markets for high-intensity sweeteners, including oral care and non-alcoholic beverages, among others, are expected to grow at CAGRs of between 3% and 8% during calendar years 2023 to 2026.

Peer Comparison:

No Listed Industry Peers

Blue Jet Healthcare Ltd Key Points

Strengths

Large manufacturer of contrast media intermediates in India.

Presence in niche categories with high barriers to entry.

Long-standing relationships and multi-year contracts with multi-national customers.

Strong product development and process optimization capabilities with a focus on sustainability.

Risk

The company's business is dependent on the sale of its products to a few key customers, including those in Europe and the United States, which are regulated markets. The loss of one or more such customers, the deterioration of their financial condition or prospects, or a reduction in their demand for its products could adversely affect its business, results of operations, financial condition and cash flows.

If the company is not able to commercialize new products in a timely manner, its business, financial condition and prospects will be adversely affected.

The company's inability to successfully expand its production capacity could have an adverse effect on its business, results of operations, financial condition and cash flows.

Strategy

Continue to forward integrate into more advanced intermediates for Contrast Media.

Leverage its long-standing customer relationships to continue entering adjacencies in the pharma intermediate and API category.

Build additional production capacity to keep in step with the envisaged increase in customer demands.

Continue to invest in R&D infrastructure and capabilities.

Focus on operational efficiency and mitigation of supply chain risks.

How To Apply for Blue Jet Healthcare Ltd IPO Online?

Step 1:

Step 2:

From the list of open IPOs, select the IPO you want to invest.

Step 3:

Go through the IPO details like lot size, price band, about the company, etc.

Step 4:

Click ‘Apply IPO’ to apply and enter the number of lots and bidding price along with your UPI ID.

Step 5:

Confirm your bid and accept the payment mandate sent to your UPI App for completing the IPO application.

FAQs on IPO (Initial Public Offering)

What is the issue size of the Blue Jet Healthcare Ltd IPO?

Blue Jet Healthcare Ltd's IPO offers shares for up to 0 It begins on Oct 25, 2023 and ends on Oct 27, 2023.

What is the price of the Blue Jet Healthcare Ltd IPO?

The price of Blue Jet Healthcare Ltd IPO ranges between ₹329 to ₹346 per share.

What are the open and close dates for the Blue Jet Healthcare Ltd IPO?

The Blue Jet Healthcare Ltd IPO opens on Oct 25, 2023 and closes on Oct 27, 2023.

When will the Blue Jet Healthcare Ltd IPO be allotted?

The allotment for the Blue Jet Healthcare Ltd IPO will be finalised on Oct 30, 2023. The shares will be listed on BSE and NSE on Nov 1, 2023.

What is the minimum lot size required for Blue Jet Healthcare Ltd IPO?

The minimum lot size for Blue Jet Healthcare Ltd IPO is 43 shares, priced between ₹329 to ₹346 per share.

What is the GMP of Blue Jet Healthcare Ltd IPO?

The GMP (Grey Market Premium) of Blue Jet Healthcare Ltd IPO fluctuates based on market demand and sentiment.

How do you check the allotment status of Blue Jet Healthcare Ltd IPO?

To check the allotment status of Blue Jet Healthcare Ltd IPO, visit the registrar's website, select the IPO, enter your PAN Card number, Application Number, or DP Client ID, and click 'search.'

Where is the Blue Jet Healthcare Ltd IPO getting listed?

The Blue Jet Healthcare Ltd IPO is getting listed on the BSE and NSE. Bidding opens on Oct 25, 2023, and closes on Oct 27, 2023. The allotment is finalised on Oct 30, 2023.

How do you apply for the Blue Jet Healthcare Ltd IPO?

To apply for the Blue Jet Healthcare Ltd IPO, download the BlinkX app, complete KYC, select the IPO, enter bid details, and submit. Verify UPI payment for shares allotment.